Upgrades:
Intel Corporation (NASDAQ:INTC) was upgraded by stock
analysts at BMO Capital Markets from a “market perform” rating to an
“outperform” rating in a research report issued to clients and investors on
Monday. Other equities analysts have also recently issued reports about the
company. Canaccord Genuity restated a “buy” rating and set a $38.00 price
objective on shares of Intel Corporation in a research note on Wednesday, July
12th. Hilliard Lyons initiated coverage on Intel Corporation in a research note
on Wednesday, July 12th. They set a “buy” rating and a $41.00 price objective
on the stock. Needham & Company LLC restated a “buy” rating and set a
$43.00 price objective on shares of Intel Corporation in a research note on
Wednesday, July 12th. Read more …
Merck & Company, Inc. (NYSE:MRK) was upgraded by
equities researchers at Citigroup Inc. to a “buy” rating in a report released
on Monday. A number of other research firms have also recently weighed in on
MRK. Zacks Investment Research cut Merck & from a “hold” rating to a “sell”
rating in a report on Wednesday, October 11th. BMO Capital Markets reaffirmed a
“buy” rating and set a $72.00 price target on shares of Merck & in a report
on Friday, September 8th. UBS AG raised their price target on Merck & from
$70.00 to $72.00 and gave the company a “buy” rating in a report on Monday,
July 31st. Piper Jaffray Companies set a $70.00 price target on Merck & and
gave the company a “buy” rating in a report on Saturday, July 29th. Finally,
BidaskClub raised Merck & from a “sell” rating to a “hold” rating in a
research note on Tuesday, August 1st. Two investment analysts have rated the
stock with a sell rating, ten have issued a hold rating and nine have assigned
a buy rating to the stock. The company currently has a consensus rating of
“Hold” and a consensus target price of $69.21. Read more …
Goldman Sachs Group, Inc. (The) upgraded shares of ABB Ltd
(NYSE:ABB) from a neutral rating to a conviction-buy rating in a research note
issued to investors on Tuesday morning. A number of other research analysts
have also recently commented on ABB. BidaskClub cut shares of ABB from a buy
rating to a hold rating in a research report on Tuesday, August 1st. Robert W.
Baird reaffirmed a buy rating and issued a $29.00 target price on shares of ABB
in a research report on Wednesday, October 4th. Zacks Investment Research cut
shares of ABB from a hold rating to a sell rating in a research report on
Tuesday, September 19th. UBS AG reaffirmed a sell rating on shares of ABB in a
research report on Monday, July 24th. Read more …
Kimberly-Clark Corporation (NYSE:KMB) was upgraded by
research analysts at Societe Generale from a “hold” rating to a “buy” rating in
a report released on Thursday, Marketbeat Ratings reports. The brokerage
currently has a $144.00 price objective on the stock, up from their prior price
objective of $112.05. Societe Generale’s price objective suggests a potential
upside of 27.99% from the stock’s previous close. A number of other analysts
have also weighed in on the company. J P Morgan Chase & Co lowered
Kimberly-Clark Corporation from a “neutral” rating to an “underweight” rating
and lowered their target price for the stock from $115.55 to $100.00 in a report
on Friday, October 20th. Macquarie initiated coverage on Kimberly-Clark
Corporation in a report on Friday, September 15th. Read more …
Downgrades:
General Motors Company (NYSE:GM) (TSE:GMM.U) was downgraded
by analysts at Goldman Sachs Group, Inc. (The) from a “neutral” rating to a
“sell” rating in a research report issued on Monday. They presently have a
$32.00 price target on the auto manufacturer’s stock, down from their previous
price target of $43.16. Goldman Sachs Group, Inc. (The)’s target price would
indicate a potential downside of 25.55% from the stock’s current price. A
number of other equities analysts have also issued reports on the stock.
Deutsche Bank AG boosted their target price on shares of General Motors from
$51.00 to $52.00 and gave the stock a “buy” rating in a research report on
Wednesday, October 25th. BMO Capital Markets raised shares of General Motors to
a “market perform” rating and boosted their target price for the stock from
$41.00 to $48.00 in a research report on Wednesday, October 25th. Read more …
Merck & Company, Inc. (NYSE:MRK) was downgraded by
Morgan Stanley from an “overweight” rating to an “equal weight” rating in a
note issued to investors on Monday, Marketbeat reports. They currently have a
$56.00 target price on the stock. Morgan Stanley’s target price points to a
potential downside of 3.85% from the company’s current price. Other equities
research analysts also recently issued reports about the company. BMO Capital
Markets restated an “outperform” rating and issued a $73.00 price target (down
from $74.00) on shares of Merck & in a report on Monday, July 24th. Read more …
Statoil ASA (NYSE:STO) was downgraded by analysts at
Citigroup Inc. from a “buy” rating to a “neutral” rating in a report issued on
Monday. Several other brokerages have also recently commented on STO. BNP
Paribas upgraded shares of Statoil ASA from an “underperform” rating to a
“neutral” rating in a research report on Tuesday, September 26th. Tudor
Pickering cut shares of Statoil ASA from a “buy” rating to a “hold” rating in a
research report on Tuesday, September 5th. Deutsche Bank AG upgraded shares of
Statoil ASA from a “sell” rating to a “hold” rating in a research report on
Monday, September 4th. Scotiabank set a $17.00 target price on shares of Statoil
ASA and gave the company a “hold” rating in a research report on Friday, August
25th. Read more …
Nokia Corporation (NYSE:NOK) was downgraded by equities
research analysts at Argus from a “buy” rating to a “hold” rating in a research
report issued to clients and investors on Monday. NOK has been the subject of
several other reports. Zacks Investment Research lowered Nokia Corporation from
a “buy” rating to a “hold” rating in a research report on Monday, July 17th.
Vetr raised Nokia Corporation from a “buy” rating to a “strong-buy” rating and
set a $7.28 target price for the company in a research report on Friday, July
14th. Read more …
Bank of America Corporation downgraded shares of Under
Armour Inc (NYSE:UAA) from a neutral rating to an underperform rating in a
report issued on Monday. They currently have $12.00 price target on the stock,
down from their prior price target of $21.00. Several other research firms also
recently weighed in on UAA. Zacks Investment Research upgraded Under Armour
from a hold rating to a buy rating and set a $24.00 target price on the stock
in a research report on Tuesday, July 4th. Vetr upgraded Under Armour from a
hold rating to a buy rating and set a $22.36 price objective on the stock in a
research report on Monday, July 3rd. Susquehanna Bancshares Inc lifted their
price objective on Under Armour from $14.00 to $17.00 in a research report on
Friday, July 7th. Read more …
Under Armour Inc (NYSE:UAA) was downgraded by equities
researchers at J P Morgan Chase & Co from a “neutral” rating to an
“underweight” rating in a report released on Tuesday. Read more …
Argus downgraded shares of Amgen Inc. (NASDAQ:AMGN) from a
buy rating to a hold rating in a research report report published on Wednesday.
The brokerage currently has $195.00 price objective on the medical research
company’s stock, up from their prior price objective of $175.22. “We would
consider a more constructive stance on AMGN on signs of stronger contributions
from the company’s new drug pipeline or from its biosimilars portfolio,” the
firm said.”We note, however, that Amgen may not generate commercial revenue
from biosimilars until 2019 due to regulatory and legal hurdles.,” Argus’
analyst wrote. Read more …
Teva Pharmaceutical Industries Limited (NYSE:TEVA) was
downgraded by research analysts at Wells Fargo & Company to a “market perform”
rating in a research note issued to investors on Thursday, The Fly reports.
They presently have a $11.36 target price on the stock, down from their
previous target price of $17.00. Wells Fargo & Company’s price objective
suggests a potential downside of 17.68% from the stock’s current price. A
number of other research firms have also issued reports on TEVA. TheStreet
lowered shares of Teva Pharmaceutical Industries Limited from a “c-” rating to
a “d+” rating in a research note on Friday, August 25th. Read more …
Teva Pharmaceutical Industries Limited (NYSE:TEVA) was
downgraded by equities researchers at Deutsche Bank AG from a “buy” rating to a
“hold” rating in a research note issued to investors on Friday. Read more …
Royal Dutch Shell PLC (NYSE:RDS.B) was downgraded by
analysts at Societe Generale from a “buy” rating to a “hold” rating in a
research note issued on Friday, The Fly reports. Read more …
No comments:
Post a Comment